Filtered By:
Drug: Velcade
Procedure: Bone Marrow Transplant
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Light chain amyloidosis: Experience in a tertiary hospital: 2005–2013
Conclusions Cardiac involvement is the major determinant of prognosis. Yield of involved organ biopsy is high (100% heart biopsies). Antineoplastic treatment with bortezomib and/or autologous bone marrow transplantation achieves hematological responses with improvements in organ impairment.
Source: Revista Clinica Espanola - November 27, 2014 Category: Internal Medicine Source Type: research
